See analyst estimates and all valuation multiples for Small Molecules
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $4.6B | 25.8x | 78.3x | |
| $3.8B | 8.3x | 21.5x | |
| $3.5B | 33.8x | -44.5x | |
| $3.2B | 122.1x | -92.6x | |
| $2.7B | 3.4x | 18.1x | |
| $2.2B | 11.8x | -7.1x | |
| $2.0B | 7.1x | 17.9x | |
| $1.9B | 0.8x | 5.5x | |
| $1.3B | 5.9x | 28.3x | |
| $1.3B | 5.5x | 15.9x | |
| $980M | n/a | n/a | |
| $930M | n/a | n/a | |
| $893M | 4.4x | 18.3x | |
| $760M | 3.3x | 34.2x | |
| $671M | 7.6x | 21.5x | |
| $585M | 78.0x | -3.2x | |
| $498M | 6.1x | n/a | |
| $322M | 1.7x | 5.9x | |
| $251M | 3.3x | -3.5x | |
| $210M | 5.8x | n/a | |
| $171M | 6.2x | -7.2x | |
| $136M | n/a | -6.1x | |
| $131M | 1.3x | -17.2x | |
| $129M | n/a | n/a | |
| $118M | n/a | -25.3x | |
| $79.3M | n/a | -0.6x | |
| $78.7M | 0.8x | -1.9x | |
| $51.7M | 1.4x | n/a | |
| $14.4M | n/a | -0.1x | |
| $4.1M | 0.1x | -0.0x | |
| -$30.7M | n/a | n/a | |
| -$34.9M | -10.9x | n/a | |
| -$190M | -6.2x | 0.8x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Small Molecules